Rennova Health, Inc. is a provider of an expanding group of health care services for healthcare providers, their patients, and individuals. The Company offers products and services, including laboratory diagnostics such as blood and urine drug toxicology testing services, healthcare technology solutions, and revenue cycle management solutions, as well as intends to provide financial services in the form of loans to physician practices.

Type
Public
HQ
West Palm Beach, US
Founded
1995
Size (employees)
116 (est)
Rennova Health was founded in 1995 and is headquartered in West Palm Beach, US
Report incorrect company information

Rennova Health Office Locations

Rennova Health has offices in West Palm Beach, Tustin, Miami, Waldwick and in 1 other location
West Palm Beach, US (HQ)
800 400 S Australian Ave
Las Cruces, US
410 Foster Rd
Miami, US
Miami International Business Center 3399 NW 72nd Ave
Tustin, US
14351 Myford Rd
Waldwick, US
71 Franklin Turnpike
West Palm Beach, US
7960 Central Industrial Dr
Show all (6)
Report incorrect company information

Rennova Health Financials and Metrics

Rennova Health Financials

Rennova Health's revenue was reported to be $5.25 m in FY, 2016 which is a 71.5% decrease from the previous period.
USD

Market capitalization (31-Oct-2017)

308.8 k

Closing share price (31-Oct-2017)

0.3

Cash (30-Sep-2017)

41 k

EV

1.8 m
Rennova Health's current market capitalization is $308.8 k.
Annual
USDFY, 2014FY, 2015FY, 2016

Revenue

57.9 m18.4 m5.2 m

Revenue growth, %

(68%)(71%)

Cost of goods sold

15.9 m9.3 m1.7 m

Gross profit

42 m9.1 m3.5 m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q1, 2016Q2, 2016Q3, 2016Q2, 2017

Revenue

251 k56 k64 k176 k94 k108 k116 k1.9 m3.1 m290 k898.7 k

Cost of goods sold

18 k104 k18 k18 k18 k26 k26 k

Gross profit

233 k(48 k)46 k158 k76 k82 k90 k

Gross profit Margin, %

93%(86%)72%90%81%76%78%
Annual
USDFY, 2014FY, 2015FY, 2016

Cash

2.4 m8.8 m78 k

Accounts Receivable

17.5 m8.1 m1.5 m

Current Assets

20.3 m22 m3.2 m

PP&E

7.7 m7.1 m3.1 m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2017Q3, 2017

Cash

2.8 m2.4 m2.1 m1.1 m193 k4.9 m485.2 k514.3 k27.7 k41 k

Accounts Receivable

250 k55 k124 k73 k47 k7.1 m7.8 m2.7 m392.2 k401 k

Inventories

227.7 k146.7 k

Current Assets

3.5 m3.1 m2.8 m1.7 m805 k15.8 m12.4 m4.7 m2.1 m2.2 m
Annual
USDFY, 2014FY, 2015FY, 2016

Net Income

7.8 m(36 m)(32.6 m)

Depreciation and Amortization

3 m

Accounts Payable

(905.6 k)

Cash From Operating Activities

7.7 m(12.6 m)(19.9 m)
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q1, 2016Q2, 2016Q3, 2016Q2, 2017

Net Income

(563 k)(1 m)(1.1 m)(1.3 m)(956 k)(5.9 m)(12 m)

Depreciation and Amortization

727.3 k701.7 k702.3 k

Inventories

227.7 k

Accounts Payable

276 k156 k175 k420 k289 k3.4 m3.8 m2.6 m3.3 m
USDY, 2017

Financial Leverage

-0.3 x
Show all financial metrics
Report incorrect company information